Precivity-ApoE™
Use
The Precivity-ApoE test is used to determine the apolipoprotein E (ApoE) genotype, which is significant in assessing the genetic risk factor associated with Alzheimer's disease. Knowledge of a patient's ApoE status can assist in tailoring treatment decisions, particularly in considering disease-modifying therapies.
Special Instructions
Not provided.
Limitations
A positive test result indicates an increased genetic risk but does not confirm Alzheimer's disease or predict its development. Interpretation should consider family history, clinical symptoms, and other risk factors.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
APOE
Gene
Result Turnaround Time
10 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
10 mL
Minimum Volume
7 mL
Container
Lavender top (EDTA) tube
Collection Instructions
Collect blood in EDTA tubes to maintain sample integrity. Samples should be frozen if processing does not occur immediately.
Patient Preparation
Standard blood draw procedure.
Storage Instructions
Store blood samples at frozen temperatures to preserve DNA integrity until testing.
Causes for Rejection
Poor sample handling, coagulation, or contamination.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 1 month |